RT Journal Article
T1 Second-hand smoke exposure in adulthood and lower respiratory health during 20 year follow up in the European Community Respiratory Health Survey.
A1 Flexeder, Claudia
A1 Zock, Jan-Paul
A1 Jarvis, Deborah
A1 Verlato, Giuseppe
A1 Olivieri, Mario
A1 Benke, Geza
A1 Abramson, Michael J
A1 Sigsgaard, Torben
A1 Svanes, Cecilie
A1 Torén, Kjell
A1 Nowak, Dennis
A1 Jõgi, Rain
A1 Martinez-Moratalla, Jesús
A1 Demoly, Pascal
A1 Janson, Christer
A1 Gislason, Thorarinn
A1 Bono, Roberto
A1 Holm, Mathias
A1 Franklin, Karl A
A1 Garcia-Aymerich, Judith
A1 Siroux, Valérie
A1 Leynaert, Bénédicte
A1 Dorado Arenas, Sandra
A1 Corsico, Angelo Guido
A1 Pereira-Vega, Antonio
A1 Probst-Hensch, Nicole
A1 Urrutia Landa, Isabel
A1 Schulz, Holger
A1 Heinrich, Joachim
K1 Adults
K1 Asthma
K1 Bronchitis
K1 ECRHS
K1 Lung function
K1 Respiratory symptoms
K1 Smoking
AB Early life exposure to tobacco smoke has been extensively studied but the role of second-hand smoke (SHS) for new-onset respiratory symptoms and lung function decline in adulthood has not been widely investigated in longitudinal studies. Our aim is to investigate the associations of exposure to SHS in adults with respiratory symptoms, respiratory conditions and lung function over 20 years. We used information from 3011 adults from 26 centres in 12 countries who participated in the European Community Respiratory Health Surveys I-III and were never or former smokers at all three surveys. Associations of SHS exposure with respiratory health (asthma symptom score, asthma, chronic bronchitis, COPD) were analysed using generalised linear mixed-effects models adjusted for confounding factors (including sex, age, smoking status, socioeconomic status and allergic sensitisation). Linear mixed-effects models with additional adjustment for height were used to assess the relationships between SHS exposure and lung function levels and decline. Reported exposure to SHS decreased in all 26 study centres over time. The prevalence of SHS exposure was 38.7% at baseline (1990-1994) and 7.1% after the 20-year follow-up (2008-2011). On average 2.4% of the study participants were not exposed at the first, but were exposed at the third examination. An increase in SHS exposure over time was associated with doctor-diagnosed asthma (odds ratio (OR): 2.7; 95% confidence interval (95%-CI): 1.2-5.9), chronic bronchitis (OR: 4.8; 95%-CI: 1.6-15.0), asthma symptom score (count ratio (CR): 1.9; 95%-CI: 1.2-2.9) and dyspnoea (OR: 2.7; 95%-CI: 1.1-6.7) compared to never exposed to SHS. Associations between increase in SHS exposure and incidence of COPD (OR: 2.0; 95%-CI: 0.6-6.0) or lung function (β: - 49 ml; 95%-CI: -132, 35 for FEV1 and β: - 62 ml; 95%-CI: -165, 40 for FVC) were not apparent. Exposure to second-hand smoke may lead to respiratory symptoms, but this is not accompanied by lung function changes.
YR 2019
FD 2019-02-14
LK http://hdl.handle.net/10668/13568
UL http://hdl.handle.net/10668/13568
LA en
DS RISalud
RD Mar 12, 2025